They are also increasing their medication adherence programs to ensure that eligible patients are properly utilizing this new class of drugs
Jastreboff, MD, PhD, Professor of Medicine at Yale University School of Medicine and Director of the Y-Weight Obesity Research Center, will discuss the pivotal Phase 3 TRIUMPH-1 trial evaluating the safety and efficacy of retatrutide in people with obesity
The company recommends most patients begin with the 4-month "Jumpstart" program
Or what weight loss plan is best for me and my goals
This is why its often talked about in the context of muscle growth, fat metabolism, and tissue recovery
Similar to SubQ injections, your prescription may list the amount in mL, units or both